Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis.

[1]  J. Hodgin,et al.  Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis , 2022, Journal of the American Society of Nephrology : JASN.

[2]  B. Rovin,et al.  KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. , 2021, Kidney international.

[3]  S. Waikar,et al.  Subtyping CKD Patients by Consensus Clustering: The Chronic Renal Insufficiency Cohort (CRIC) Study. , 2021, Journal of the American Society of Nephrology : JASN.

[4]  M. Kretzler,et al.  Integrated multi-omics approaches to improve classification of chronic kidney disease , 2020, Nature Reviews Nephrology.

[5]  M. Kretzler,et al.  JAK-STAT Activity in Peripheral Blood Cells and Kidney Tissue in IgA Nephropathy. , 2020, Clinical journal of the American Society of Nephrology : CJASN.

[6]  Paul J. Hoover,et al.  Single cell transcriptomics identifies focal segmental glomerulosclerosis remission endothelial biomarker. , 2020, JCI insight.

[7]  V. Nair,et al.  Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis , 2019, PloS one.

[8]  V. Puri,et al.  Bioinformatics Unmasks the Maneuverers of Pain Pathways in Acute Kidney Injury , 2019, Scientific Reports.

[9]  J. Privratsky,et al.  KLF4 in Macrophages Attenuates TNFα-Mediated Kidney Injury and Fibrosis. , 2019, Journal of the American Society of Nephrology : JASN.

[10]  Masato Hoshi,et al.  A single-nucleus RNA-sequencing pipeline to decipher the molecular anatomy and pathophysiology of human kidneys , 2019, Nature Communications.

[11]  J. Ioannidis,et al.  New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology. , 2019, Cancer treatment reviews.

[12]  B. Gillespie,et al.  Using All Longitudinal Data to Define Time to Specified Percentages of Estimated GFR Decline: A Simulation Study. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  Benjamin S. Freedman,et al.  Organoid single-cell profiling identifies a transcriptional signature of glomerular disease , 2018, bioRxiv.

[14]  G. Gambaro,et al.  DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS. , 2018, Journal of the American Society of Nephrology : JASN.

[15]  M. Kretzler,et al.  JAK-STAT signaling is activated in the kidney and peripheral blood cells of patients with focal segmental glomerulosclerosis. , 2018, Kidney international.

[16]  S. Furth,et al.  Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease. , 2018, Kidney international.

[17]  Anand Srivastava,et al.  The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study. , 2018, Journal of the American Society of Nephrology : JASN.

[18]  Casey S Greene,et al.  Metabolic pathways and immunometabolism in rare kidney diseases , 2018, Annals of the rheumatic diseases.

[19]  Priyamvada Singh,et al.  Association of Pathological Fibrosis With Renal Survival Using Deep Neural Networks , 2018, Kidney international reports.

[20]  J. Sáez-Rodríguez,et al.  Perturbation-response genes reveal signaling footprints in cancer gene expression , 2016, Nature Communications.

[21]  W. Han,et al.  TNF-α-induced Inflammation Stimulates Apolipoprotein-A4 via Activation of TNFR2 and NF-κB Signaling in Kidney Tubular Cells , 2017, Scientific Reports.

[22]  J. Kopp,et al.  Focal Segmental Glomerulosclerosis. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[23]  E. Inwald,et al.  Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro , 2016, BMC Cancer.

[24]  C. Forsblom,et al.  Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury. , 2016, The Journal of clinical investigation.

[25]  P. Kimmel,et al.  Genomic approaches to the burden of kidney disease in Sub-Saharan Africa: the Human Heredity and Health in Africa (H3Africa) Kidney Disease Research Network. , 2016, Kidney international.

[26]  S. Hewitt,et al.  Reproducibility of the NEPTUNE descriptor-based scoring system on whole-slide images and histologic and ultrastructural digital images , 2016, Modern Pathology.

[27]  Catherine C. Robertson,et al.  Using Population Genetics to Interrogate the Monogenic Nephrotic Syndrome Diagnosis in a Case Cohort. , 2016, Journal of the American Society of Nephrology : JASN.

[28]  J. Lieske,et al.  Complete Remission in the Nephrotic Syndrome Study Network. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[29]  P. Kimmel,et al.  Human Heredity and Health (H3) in Africa Kidney Disease Research Network: A Focus on Methods in Sub-Saharan Africa. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[30]  K. Shedden,et al.  Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker , 2015, Science Translational Medicine.

[31]  T. Srivastava,et al.  Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group , 2015, BMC Nephrology.

[32]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[33]  Benjamin J. Keller,et al.  Integrative biology identifies shared transcriptional networks in CKD. , 2014, Journal of the American Society of Nephrology : JASN.

[34]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[35]  M. Arnaout,et al.  Abatacept in B7-1-positive proteinuric kidney disease. , 2013, The New England journal of medicine.

[36]  R. Lafayette,et al.  Treatment of idiopathic FSGS with adrenocorticotropic hormone gel. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[37]  John Tomaszewski,et al.  Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE). , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[38]  V. D’Agati,et al.  Association of histologic variants in FSGS clinical trial with presenting features and outcomes. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[39]  Chrysta Lienczewski,et al.  Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multi-disciplinary approach , 2012, Kidney international.

[40]  M. Seifert,et al.  Detecting and visualizing gene fusions. , 2013, Methods.

[41]  F. Tam,et al.  Urinary monocyte chemoattractant protein-1 in renal disease. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[42]  F. Collins.  Reengineering Translational Science: The Time Is Right , 2011, Science Translational Medicine.

[43]  S. Ito,et al.  Long-term remission of nephrotic syndrome with etanercept for concomitant juvenile idiopathic arthritis , 2010, Pediatric Nephrology.

[44]  Matthew D. Wilkerson,et al.  ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..

[45]  K. Shedden,et al.  NFkappaB promotes inflammation, coagulation, and fibrosis in the aging glomerulus. , 2010, Journal of the American Society of Nephrology : JASN.

[46]  D. Gipson,et al.  Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group , 2010, BMC nephrology.

[47]  D. Gipson,et al.  Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[48]  G. Schwartz,et al.  Measurement and estimation of GFR in children and adolescents. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[49]  T. Mayadas,et al.  Immunoregulatory role of TNFalpha in inflammatory kidney diseases. , 2009, Kidney international.

[50]  Doheon Lee,et al.  Inferring Pathway Activity toward Precise Disease Classification , 2008, PLoS Comput. Biol..

[51]  C. Ware.  The TNF Superfamily-2008. , 2008, Cytokine & growth factor reviews.

[52]  A. E. El Nahas,et al.  Localization of matrix metalloproteinases and their inhibitors in experimental progressive kidney scarring. , 2007, Kidney international.

[53]  Felix Eichinger,et al.  Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy , 2006, Diabetes.

[54]  C. Cohen,et al.  Gene expression profiling analysis in nephrology: towards molecular definition of renal disease , 2006, Clinical and Experimental Nephrology.

[55]  C. Usal,et al.  Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats. , 2005, Kidney international.

[56]  John D. Storey,et al.  A network-based analysis of systemic inflammation in humans , 2005, Nature.

[57]  D. Raveh,et al.  Tumor necrosis factor-α blocking agent as a treatment for nephrotic syndrome , 2004, Pediatric Nephrology.

[58]  A. Bakr,et al.  Tumor necrosis factor-α production from mononuclear cells in nephrotic syndrome , 2003, Pediatric Nephrology.

[59]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[60]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[61]  V. Savin,et al.  TNF-alpha increases albumin permeability of isolated rat glomeruli through the generation of superoxide. , 1998, Journal of the American Society of Nephrology : JASN.

[62]  L. Baud,et al.  Tumor necrosis factor alpha and mesangial cells. , 1992, Kidney international.

[63]  M. Jäättelä.  Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin. , 1991, Laboratory investigation; a journal of technical methods and pathology.